Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Nature Communications2016Vol. 7(1), pp. 12150–12150
Citations Over TimeTop 1% of 2016 papers
Vincenzo Bronte, Sven Brandau, Shu‐Hsia Chen, Mario P. Colombo, Alan B. Frey, Tim F. Greten, Susanna Mandruzzato, Peter J. Murray, Augusto C. Ochoa, Suzanne Ostrand‐Rosenberg, Paulo C. Rodrı́guez, Antonio Sica, Viktor Umansky, Robert H. Vonderheide, Dmitry I. Gabrilovich
Abstract
Myeloid-derived suppressor cells (MDSCs) have emerged as major regulators of immune responses in cancer and other pathological conditions. In recent years, ample evidence supports key contributions of MDSC to tumour progression through both immune-mediated mechanisms and those not directly associated with immune suppression. MDSC are the subject of intensive research with >500 papers published in 2015 alone. However, the phenotypic, morphological and functional heterogeneity of these cells generates confusion in investigation and analysis of their roles in inflammatory responses. The purpose of this communication is to suggest characterization standards in the burgeoning field of MDSC research.
Related Papers
- → Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases(2017)3 cited
- Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals.(1986)
- → Supplementary Data from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells(2023)
- MiR-6991-3p is identified as a novel suppressor in the expansion and activation of myeloid-derived suppressor cells in hepatoma-bearing mice(2018)